My MP had contacted the chief executive of my nearest NHS Primary Care Trust (PCT) to answer my concern over allegations that GPs were being discouraged from prescribing the Neupro patch and, possibly, pramipexole because of blacklisting due to the cost. Both meds are important to RLS sufferers. I have received the reply and can report the outcome. Any words in capitals will be emphasis not anger. The response goes a long way in possibly explaining the problems that some of us have had in getting RLS meds from out GPs.
I suspect that my area is not alone in that the local PCT has a "formulary". These contain names of meds that been examined for clinical and COST effectiveness. They are subdivided into four categories: green - GPs can precribe any of these; amber - initiated normally by a specialist consultant as the knowledge of their use may be beyond most GPs; red - only for use in secondary care (no, don't know what that is!) and blue - can only be given after authorisation at trust level. The response goes on to say that very few drugs are actually blacklisted but if they are it's because of national advice or that they are not recommended locally. They will not be locally recommended if evidence for their benefit is insufficient or they are NOT COST EFFECTIVE. These are decided by a national body for health and clinical effectiveness (NICE - an acronym not emphasis) based on a measure of Qualified Adjusted Life Years. To my horror, when I googled that expression it says that it is a measure of VALUE FOR MONEY of a treatment for someone, so, yes, folks our lives HAVE been costed up by some economist and/or politico somewhere. Also Neupro and pramipexole are deemed to be drugs for Parkinson's Disease so their use in treating RLS seems surprising to the powers that be.
So this may reassure concerns about an amber list being a "danger of removal list" mentioned previously by other posters. It may also explain why a GP may not prescribe you the patch on their own because they don't know much about RLS (not uncommonly reported on these pages) and are worried about prescribing Neupro etc. This could be the case in my situation because the Neupro patch was recommended to one of my GPs by a SLEEP CONSULTANT whom the second GP who refused prescription had had no dealings with. Finally our meds should NOT be blacklisted (officially at least) but cost effectiveness clearly does come into the equation. With the new NHS legislation coming into effect next year and NHS budgets already tightening, one can see that GPs may choose not to prescribe our meds because of the cost. I hope that is not the case.
I have tried to be unbiased and reportive in the above: one can feel either reassured or not depending on how cynical you are. We need to keep on our guard and act swiftly and positively whenever necessary. All the best, Tpebop, Kent, British Isles.